NRG 200 MIDTERM EXAM 300 ACTUAL
QUESTIONS AND CORRECT ANSWERS WITH
RATIONALE LATEST UPDATE ALREADY
GRADED A+ ASSURED PASS
This comprehensive 300-question study guide is designed to prepare you for the
NRG 200 Midterm Exam. Organized into eight sections, it covers foundational
pharmacology principles, dose calculations, cardiovascular and renal drugs, central
nervous system agents, endocrine and anti-inflammatory medications,
antimicrobial therapy, pain management and opioid safety, and medication safety
for special populations. Each multiple-choice question includes a correct answer
and a detailed rationale to reinforce your understanding of pharmacokinetics,
pharmacodynamics, drug interactions, and nursing implications. Use this guide to
test your knowledge of safe medication administration, therapeutic effects, and
adverse reactions. For best results, combine this review with your course materials
and focus on clinical application and patient safety.
Section 1: Foundational Principles of Pharmacology (Questions 1-40)
1. The study of how a drug moves through the body, including absorption,
distribution, metabolism, and excretion, is known as:
A) Pharmacodynamics
B) Pharmacokinetics
C) Pharmacotherapeutics
D) Pharmacogenomics
Answer: B
Rationale: Pharmacokinetics describes what the body does to the drug,
encompassing the four processes of absorption, distribution, metabolism, and
excretion. Pharmacodynamics, in contrast, describes what the drug does to the
body .
2. What is the primary site of drug metabolism in the body?
,A) Kidneys
B) Liver
C) Lungs
D) Pancreas
Answer: B
Rationale: The liver is the primary site of drug metabolism, containing the
cytochrome P450 enzyme system that transforms drugs into more water-soluble
forms for excretion .
3. What does a drug's half-life indicate?
A) Time for complete elimination from the body
B) Time required for the plasma concentration to decrease by half
C) Time to reach peak therapeutic effect
D) Time required for absorption
Answer: B
Rationale: Half-life is the time required for the plasma concentration of a drug to
decrease by one-half. It takes approximately 4-5 half-lives for a drug to reach
steady state and for it to be eliminated from the body .
4. The term for the official, non-proprietary name of a drug, which remains
consistent across manufacturers, is:
A) Brand name
B) Trade name
C) Generic name
D) Chemical name
Answer: C
Rationale: The generic name is the official, non-proprietary name assigned to a
drug. It remains consistent across manufacturers, unlike brand/trade names which
vary .
5. A drug with high protein binding will have:
A) More free drug available for therapeutic effect
B) Less free drug available for therapeutic effect
C) Faster renal excretion
D) No effect on drug activity
Answer: B
Rationale: Only unbound (free) drug molecules can bind to receptors and produce
therapeutic effects. Highly protein-bound drugs (e.g., warfarin, 99% bound) have
limited free drug available .
,6. Which organ is primarily responsible for drug excretion?
A) Liver
B) Lungs
C) Kidneys
D) Skin
Answer: C
Rationale: The kidneys are the primary organs responsible for drug excretion,
eliminating water-soluble drug metabolites through urine. Impaired renal function
reduces drug clearance, leading to accumulation and potential toxicity .
7. What is the "first-pass effect"?
A) The drug is absorbed quickly from the stomach
B) A large portion of the drug is metabolized by the liver before reaching systemic
circulation
C) The drug is excreted unchanged by the kidneys
D) The drug has a rapid onset of action
Answer: B
Rationale: First-pass metabolism occurs when orally administered drugs are
absorbed from the GI tract and transported via the portal vein to the liver, where
they are partially metabolized before reaching systemic circulation .
8. Which factor places a patient at highest risk for medication toxicity?
A) Increased protein binding
B) Impaired renal function
C) Increased gastric motility
D) Rapid absorption
Answer: B
Rationale: The kidneys are the primary route of drug excretion. Impaired renal
function reduces drug clearance, leading to accumulation and potential toxicity.
Older adults and patients with chronic kidney disease are at increased risk .
9. A drug with a narrow therapeutic index requires:
A) No special monitoring
B) A larger margin of safety
C) Close monitoring of serum drug levels
D) Administration with food to prevent toxicity
Answer: C
Rationale: Drugs with a narrow therapeutic index (e.g., warfarin, digoxin, lithium)
have a small range between an effective dose and a toxic dose. They require close
monitoring of serum drug levels to ensure efficacy and prevent toxicity .
, 10. The time it takes for a drug to reach its maximum concentration in the blood is
called the:
A) Half-life
B) Onset of action
C) Peak effect
D) Duration of action
Answer: C
Rationale: Peak effect refers to the time when the drug reaches its maximum
concentration in the bloodstream and its greatest therapeutic effect .
11. A patient with liver failure is prescribed a medication that is a prodrug. The
nurse should anticipate:
A) Increased therapeutic effect
B) Decreased therapeutic effect due to impaired activation of the prodrug
C) No change in drug effect
D) Increased risk of toxicity
Answer: B
Rationale: A prodrug is an inactive compound that must be metabolized (typically
by the liver) to become an active drug. In liver failure, the metabolic capacity is
reduced, so the prodrug may not be adequately converted to its active form,
resulting in a decreased therapeutic effect .
12. A medication that binds to a receptor and produces a response is called a(n):
A) Agonist
B) Antagonist
C) Partial agonist
D) Inverse agonist
Answer: A
Rationale: Agonists bind to receptors and activate them to produce a response (e.g.,
morphine at opioid receptors). Antagonists bind without activating, blocking the
response .
13. A medication that binds to a receptor but does not activate it, blocking the
action of other drugs, is called a(n):
A) Agonist
B) Antagonist
C) Partial agonist
D) Allosteric modulator
Answer: B
QUESTIONS AND CORRECT ANSWERS WITH
RATIONALE LATEST UPDATE ALREADY
GRADED A+ ASSURED PASS
This comprehensive 300-question study guide is designed to prepare you for the
NRG 200 Midterm Exam. Organized into eight sections, it covers foundational
pharmacology principles, dose calculations, cardiovascular and renal drugs, central
nervous system agents, endocrine and anti-inflammatory medications,
antimicrobial therapy, pain management and opioid safety, and medication safety
for special populations. Each multiple-choice question includes a correct answer
and a detailed rationale to reinforce your understanding of pharmacokinetics,
pharmacodynamics, drug interactions, and nursing implications. Use this guide to
test your knowledge of safe medication administration, therapeutic effects, and
adverse reactions. For best results, combine this review with your course materials
and focus on clinical application and patient safety.
Section 1: Foundational Principles of Pharmacology (Questions 1-40)
1. The study of how a drug moves through the body, including absorption,
distribution, metabolism, and excretion, is known as:
A) Pharmacodynamics
B) Pharmacokinetics
C) Pharmacotherapeutics
D) Pharmacogenomics
Answer: B
Rationale: Pharmacokinetics describes what the body does to the drug,
encompassing the four processes of absorption, distribution, metabolism, and
excretion. Pharmacodynamics, in contrast, describes what the drug does to the
body .
2. What is the primary site of drug metabolism in the body?
,A) Kidneys
B) Liver
C) Lungs
D) Pancreas
Answer: B
Rationale: The liver is the primary site of drug metabolism, containing the
cytochrome P450 enzyme system that transforms drugs into more water-soluble
forms for excretion .
3. What does a drug's half-life indicate?
A) Time for complete elimination from the body
B) Time required for the plasma concentration to decrease by half
C) Time to reach peak therapeutic effect
D) Time required for absorption
Answer: B
Rationale: Half-life is the time required for the plasma concentration of a drug to
decrease by one-half. It takes approximately 4-5 half-lives for a drug to reach
steady state and for it to be eliminated from the body .
4. The term for the official, non-proprietary name of a drug, which remains
consistent across manufacturers, is:
A) Brand name
B) Trade name
C) Generic name
D) Chemical name
Answer: C
Rationale: The generic name is the official, non-proprietary name assigned to a
drug. It remains consistent across manufacturers, unlike brand/trade names which
vary .
5. A drug with high protein binding will have:
A) More free drug available for therapeutic effect
B) Less free drug available for therapeutic effect
C) Faster renal excretion
D) No effect on drug activity
Answer: B
Rationale: Only unbound (free) drug molecules can bind to receptors and produce
therapeutic effects. Highly protein-bound drugs (e.g., warfarin, 99% bound) have
limited free drug available .
,6. Which organ is primarily responsible for drug excretion?
A) Liver
B) Lungs
C) Kidneys
D) Skin
Answer: C
Rationale: The kidneys are the primary organs responsible for drug excretion,
eliminating water-soluble drug metabolites through urine. Impaired renal function
reduces drug clearance, leading to accumulation and potential toxicity .
7. What is the "first-pass effect"?
A) The drug is absorbed quickly from the stomach
B) A large portion of the drug is metabolized by the liver before reaching systemic
circulation
C) The drug is excreted unchanged by the kidneys
D) The drug has a rapid onset of action
Answer: B
Rationale: First-pass metabolism occurs when orally administered drugs are
absorbed from the GI tract and transported via the portal vein to the liver, where
they are partially metabolized before reaching systemic circulation .
8. Which factor places a patient at highest risk for medication toxicity?
A) Increased protein binding
B) Impaired renal function
C) Increased gastric motility
D) Rapid absorption
Answer: B
Rationale: The kidneys are the primary route of drug excretion. Impaired renal
function reduces drug clearance, leading to accumulation and potential toxicity.
Older adults and patients with chronic kidney disease are at increased risk .
9. A drug with a narrow therapeutic index requires:
A) No special monitoring
B) A larger margin of safety
C) Close monitoring of serum drug levels
D) Administration with food to prevent toxicity
Answer: C
Rationale: Drugs with a narrow therapeutic index (e.g., warfarin, digoxin, lithium)
have a small range between an effective dose and a toxic dose. They require close
monitoring of serum drug levels to ensure efficacy and prevent toxicity .
, 10. The time it takes for a drug to reach its maximum concentration in the blood is
called the:
A) Half-life
B) Onset of action
C) Peak effect
D) Duration of action
Answer: C
Rationale: Peak effect refers to the time when the drug reaches its maximum
concentration in the bloodstream and its greatest therapeutic effect .
11. A patient with liver failure is prescribed a medication that is a prodrug. The
nurse should anticipate:
A) Increased therapeutic effect
B) Decreased therapeutic effect due to impaired activation of the prodrug
C) No change in drug effect
D) Increased risk of toxicity
Answer: B
Rationale: A prodrug is an inactive compound that must be metabolized (typically
by the liver) to become an active drug. In liver failure, the metabolic capacity is
reduced, so the prodrug may not be adequately converted to its active form,
resulting in a decreased therapeutic effect .
12. A medication that binds to a receptor and produces a response is called a(n):
A) Agonist
B) Antagonist
C) Partial agonist
D) Inverse agonist
Answer: A
Rationale: Agonists bind to receptors and activate them to produce a response (e.g.,
morphine at opioid receptors). Antagonists bind without activating, blocking the
response .
13. A medication that binds to a receptor but does not activate it, blocking the
action of other drugs, is called a(n):
A) Agonist
B) Antagonist
C) Partial agonist
D) Allosteric modulator
Answer: B
